Argus Investors' Counsel, Inc. Pfizer Inc Transaction History

Argus Investors' Counsel, Inc.

$148 Million
Q3 2024

A detailed history of Argus Investors' Counsel, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 27,940 shares of PFE stock, worth $767,232. This represents 0.55% of its overall portfolio holdings.

Number of Shares

27,940

Previous 39,240 28.8%

Holding current value

$767,232

Previous $1.1 Million 26.34%

% of portfolio

0.55%

Previous 0.68%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$27.7 - $31.39 $313,010 - $354,707	-11,300 Reduced 28.8%	27,940 $808,000
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $991,202 - $1.16 Million	39,240 New	39,240 $1.1 Million
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $106,796 - $122,636	4,125 Added 9.52%	47,440 $1.32 Million
Q4 2023 Jan 19, 2024	BUY	$26.13 - $33.94 $165,925 - $215,519	6,350 Added 17.18%	43,315 $1.25 Million
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $95,628 - $111,779	2,980 Added 8.77%	36,965 $1.23 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $58,514 - $67,699	1,620 Added 5.01%	33,985 $1.25 Million
Q1 2023 Apr 20, 2023	BUY	$39.39 - $51.28 $196,950 - $256,400	5,000 Added 18.27%	32,365 $1.32 Million
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $21,918 - $28,612	-525 Reduced 1.88%	27,365 $0
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $358,832 - $438,044	-8,200 Reduced 22.72%	27,890 $1.22 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $18,612 - $22,068	-400 Reduced 1.1%	36,090 $1.89 Million
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $201,254 - $249,379	-4,399 Reduced 10.76%	36,490 $1.89 Million
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $580,546 - $860,562	-14,050 Reduced 25.57%	40,889 $2.41 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $1.62 Million - $2.08 Million	-41,180 Reduced 42.84%	54,939 $2.36 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $255,320 - $289,234	-7,110 Reduced 6.89%	96,119 $3.76 Million
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $252,246 - $284,483	7,532 Added 7.87%	103,229 $3.74 Million
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $712,342 - $905,804	-21,283 Reduced 18.19%	95,697 $3.52 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $269,875 - $316,625	8,500 Added 7.84%	116,980 $4.29 Million
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $165,660 - $200,970	5,500 Added 5.34%	108,480 $3.55 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $70,278 - $100,412	2,600 Added 2.59%	102,980 $3.36 Million
Q4 2019 Jan 17, 2020	BUY	$32.92 - $37.36 $124,997 - $141,855	3,797 Added 3.93%	100,380 $3.93 Million
Q2 2019 Jul 10, 2019	BUY	$36.98 - $41.52 $3.53 Million - $3.97 Million	95,513 Added 97.81%	193,166 $8.37 Million
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $3.57 Million - $4.01 Million	-96,583 Reduced 50.0%	96,583 $4.18 Million
Q1 2019 Apr 16, 2019	SELL	$37.5 - $41.2 $138,000 - $151,616	-3,680 Reduced 3.63%	97,653 $4.15 Million
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $341,228 - $389,038	-8,870 Reduced 8.05%	101,333 $4.42 Million
Q3 2018 Oct 16, 2018	SELL	$34.47 - $41.81 $120,472 - $146,125	-3,495 Reduced 3.07%	110,203 $0
Q2 2018 Jul 19, 2018	SELL	$32.98 - $35.16 $30,968 - $33,015	-939 Reduced 0.82%	113,698 $4.13 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $30,920 - $35,872	969 Added 0.85%	114,637 $4.09 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $32,228 - $34,196	-969 Reduced 0.85%	113,668 $4.12 Million
Q3 2017 Oct 06, 2017	BUY	$31.0 - $34.15 $3.55 Million - $3.91 Million	114,637	114,637 $4.09 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.

Account

Argus Investors' Counsel, Inc. Pfizer Inc Transaction History